• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter
May 27,2026
Net profit of Medicamen Biotech rose 59.50% to Rs 3.86 crore in the quarter ended March 2026 as against Rs 2.42 crore during the previous quarter ended March 2025. Sales rose 104.83% to Rs 60.65 crore in the quarter ended March 2026 as against Rs 29.61 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.58% to Rs 9.64 crore in the year ended March 2026 as against Rs 7.11 crore during the previous year ended March 2025. Sales rose 21.67% to Rs 197.77 crore in the year ended March 2026 as against Rs 162.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales60.6529.61 105 197.77162.55 22
OPM %8.97-5.44 -9.918.53 -
PBDT6.792.97 129 19.2016.95 13
PBT5.062.49 103 11.989.88 21
NP3.862.42 60 9.647.11 36